Provided by Tiger Trade Technology Pte. Ltd.

Abivax S.A.

117.61
+0.23000.20%
Post-market: 118.000.3900+0.33%19:45 EDT
Volume:443.37K
Turnover:52.19M
Market Cap:9.31B
PE:-20.72
High:119.06
Open:117.42
Low:115.63
Close:117.38
52wk High:148.83
52wk Low:5.59
Shares:79.19M
Float Shares:42.66M
Volume Ratio:0.51
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.6758
EPS(LYR):-5.6758
ROE:-135.58%
ROA:-38.95%
PB:17.44
PE(LYR):-20.72

Loading ...

Abivax call volume above normal and directionally bullish

TIPRANKS
·
Apr 28

Abivax appoints Michael Nesrallah as chief commercial officer

TIPRANKS
·
Apr 02

Abivax SA Sponsored ADR (ABVX) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Mar 28

Abivax SA Sponsored ADR (ABVX) Gets a Buy from Guggenheim

TIPRANKS
·
Mar 25

Stock Track | Abivax Plummets 5.33% Intraday as CEO Downplays Sale Talk and Eyes Capital Raise

Stock Track
·
Mar 25

Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears

Benzinga_recent_news
·
Mar 25

Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Talphera (TLPH) and Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Mar 24

Abivax price target raised to $148 from $142 at Barclays

TIPRANKS
·
Mar 24

Abivax SA reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 24

Abivax 2025 Net Loss Widens

MT Newswires Live
·
Mar 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 23

LifeSci Capital Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Mar 21

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 20

Abivax SA expected to post a loss of €1.28 a share - Earnings Preview

Reuters
·
Mar 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 18

European Equities Traded in the US as American Depositary Receipts Higher Monday

MT Newswires Live
·
Mar 16

Jefferies Initiates Abivax at Buy With $160 Price Target

MT Newswires Live
·
Mar 16

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics

Reuters
·
Mar 16

Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 29.21%, and institutional views are bullish

Earnings Agent
·
Mar 16

Abivax SA Sponsored ADR (ABVX) Initiated with a Buy at Leerink Partners

TIPRANKS
·
Mar 16